This AOP is licensed under the BY-SA license. This license allows reusers to distribute, remix, adapt, and build upon the material in any medium or format, so long as attribution is given to the creator. The license allows for commercial use. If you remix, adapt, or build upon the material, you must license the modified material under identical terms.

AOP: 521

Title

A descriptive phrase which references both the Molecular Initiating Event and Adverse Outcome.It should take the form “MIE leading to AO”. For example, “Aromatase inhibition leading to reproductive dysfunction” where Aromatase inhibition is the MIE and reproductive dysfunction the AO. In cases where the MIE is unknown or undefined, the earliest known KE in the chain (i.e., furthest upstream) should be used in lieu of the MIE and it should be made clear that the stated event is a KE and not the MIE.  More help

Essential element imbalance leads to reproductive failure via oxidative stress

Short name
A name that succinctly summarises the information from the title. This name should not exceed 90 characters. More help
Essential element imbalance leads to reproductive failure via oxidative stress
The current version of the Developer's Handbook will be automatically populated into the Handbook Version field when a new AOP page is created.Authors have the option to switch to a newer (but not older) Handbook version any time thereafter. More help
Handbook Version v2.6

Graphical Representation

A graphical representation of the AOP.This graphic should list all KEs in sequence, including the MIE (if known) and AO, and the pair-wise relationships (links or KERs) between those KEs. More help
Click to download graphical representation template Explore AOP in a Third Party Tool

Authors

The names and affiliations of the individual(s)/organisation(s) that created/developed the AOP. More help

Of the originating work:

Janaina da Silva (Department of General Biology, Universidade Federal de Viçosa, Viçosa, Minas Gerais, Brazil)

Reggiani Vilela Gonçalves (Department of Animal Biology, Universidade Federal de Viçosa, Viçosa, Minas Gerais, Brazil)

Fabiana Cristina Silveira Alves de Melo (Department of Animal Biology, Universidade Federal de Viçosa, Viçosa, Minas Gerais, Brazil)

Mariáurea Matias Sarandy (Department of Animal Biology, Universidade Federal de Viçosa, Viçosa, Minas Gerais, Brazil)

Sérgio Luis Pinto da Matta (Department of General Biology, Universidade Federal de Viçosa, Viçosa, Minas Gerais, Brazil and Department of Animal Biology, Universidade Federal de Viçosa, Viçosa, Minas Gerais, Brazil)

Of the content populated in the AOP-Wiki:

Travis Karschnik (General Dynamics Information Technology, Duluth, MN, USA.)

Point of Contact

The user responsible for managing the AOP entry in the AOP-KB and controlling write access to the page by defining the contributors as described in the next section.   More help
Travis Karschnik   (email point of contact)

Contributors

Users with write access to the AOP page.  Entries in this field are controlled by the Point of Contact. More help
  • Travis Karschnik

Coaches

This field is used to identify coaches who supported the development of the AOP.Each coach selected must be a registered author. More help

OECD Information Table

Provides users with information concerning how actively the AOP page is being developed and whether it is part of the OECD Workplan and has been reviewed and/or endorsed. OECD Project: Assigned upon acceptance onto OECD workplan. This project ID is managed and updated (if needed) by the OECD. OECD Status: For AOPs included on the OECD workplan, ‘OECD status’ tracks the level of review/endorsement of the AOP . This designation is managed and updated by the OECD. Journal-format Article: The OECD is developing co-operation with Scientific Journals for the review and publication of AOPs, via the signature of a Memorandum of Understanding. When the scientific review of an AOP is conducted by these Journals, the journal review panel will review the content of the Wiki. In addition, the Journal may ask the AOP authors to develop a separate manuscript (i.e. Journal Format Article) using a format determined by the Journal for Journal publication. In that case, the journal review panel will be required to review both the Wiki content and the Journal Format Article. The Journal will publish the AOP reviewed through the Journal Format Article. OECD iLibrary published version: OECD iLibrary is the online library of the OECD. The version of the AOP that is published there has been endorsed by the OECD. The purpose of publication on iLibrary is to provide a stable version over time, i.e. the version which has been reviewed and revised based on the outcome of the review. AOPs are viewed as living documents and may continue to evolve on the AOP-Wiki after their OECD endorsement and publication.   More help
OECD Project # OECD Status Reviewer's Reports Journal-format Article OECD iLibrary Published Version
This AOP was last modified on April 11, 2024 17:50

Revision dates for related pages

Page Revision Date/Time
Increased, essential element imbalance May 09, 2024 17:24
Increased, Reactive oxygen species April 10, 2024 17:33
Oxidative Stress August 26, 2024 10:26
Increase, Lipid peroxidation May 27, 2024 07:29
Increased, histomorphological alteration of testis April 10, 2024 17:39
Impaired, Spermatogenesis April 10, 2024 17:41
Decreased, Viable Offspring April 10, 2024 17:43
Increased, essential element imbalance leads to Increased, Reactive oxygen species August 02, 2024 15:07
Increased, Reactive oxygen species leads to Increased, LPO April 11, 2024 16:24
Increased, Reactive oxygen species leads to Oxidative Stress August 02, 2024 15:40
Oxidative Stress leads to Increased, LPO April 11, 2024 16:21
Increased, LPO leads to Increased, histomorphological alteration of testis April 11, 2024 16:22
Increased, histomorphological alteration of testis leads to Impaired, Spermatogenesis April 11, 2024 16:22
Impaired, Spermatogenesis leads to Decreased, Viable Offspring September 29, 2023 12:58
Cadmium October 25, 2017 08:33
Heavy metals (cadmium, lead, copper, iron, nickel) October 25, 2021 03:21

Abstract

A concise and informative summation of the AOP under development that can stand-alone from the AOP page. The aim is to capture the highlights of the AOP and its potential scientific and regulatory relevance. More help

AOP Development Strategy

Context

Used to provide background information for AOP reviewers and users that is considered helpful in understanding the biology underlying the AOP and the motivation for its development.The background should NOT provide an overview of the AOP, its KEs or KERs, which are captured in more detail below. More help

This AOP was developed as part of an Environmental Protection Agency effort to increase the impact of AOPs published in the peer-reviewed literature, but heretofore unrepresented in the AOP-Wiki, by facilitating their entry and update.  The originating work for this AOP was da Silva, J., Goncalves, R. V., de Melo, F. C. S. A., Sarandy, M. M., & da Matta, S. L. P. (2021). Cadmium exposure and testis susceptibility: A systematic review in murine models. Biological Trace Element Research, 199(7), 2663-2676. This publication, and the work cited within, were used create and support this AOP and its respective KE and KER pages.

The originating authors acknowledged that Cd induces testicular damages however the impact of Cd on the testicular architecture and the mechanisms involved in this damaging process were not clear. They went on to acknowledge that it remains poorly understood if there is a relationship between dose, route, and time of exposure and the injury intensity.  Therefore, they conducted a systematic review to assess whether Cd exposure (in any dose, route, and time of exposure) caused significant testicular tissue alterations, including any outcome of testicular histomorphology, as well as molecular, biochemical, and hormonal evaluations in order to understand the mechanisms involved in the histomorphological changes, in murine models. The authors felt this was extremely important in order to provide a direction for future research in this field and the development of decision making for therapeutic alternatives on the treatment of testicular injuries.

Strategy

Provides a description of the approaches to the identification, screening and quality assessment of the data relevant to identification of the key events and key event relationships included in the AOP or AOP network.This information is important as a basis to support the objective/envisaged application of the AOP by the regulatory community and to facilitate the reuse of its components.  Suggested content includes a rationale for and description of the scope and focus of the data search and identification strategy/ies including the nature of preliminary scoping and/or expert input, the overall literature screening strategy and more focused literature surveys to identify additional information (including e.g., key search terms, databases and time period searched, any tools used). More help

The authors perfromed a bibliography search using the electronic databases Medline/PubMed (https://www.ncbi.nlm.nih.gov/pubmed) and Scopus (https://www.scopus.com/ home.uri), on September 21, 2018, at 2:13 p.m. For all databases, the search filters were based on three complementary levels: (i) animals, (ii) testis, and (iii) cadmium, which were combined by Boolean connectors [AND].  An initial selection based on title and abstract was performed where pre-clinical studies in murine models were included that assessed the Cd effect on testicular architecture that did or did not perform molecular, biochemical, and/or hormonal analyses.  All timings, frequencies, routes, and dosages of Cd (and compounds)exposure were eligible for inclusion.  The authors excluded studies that didn't evaluate the Cd exposure in the testicular histomorphology of murine models.  Data extraction was based on (i) characteristics of publication: authors, publication year, and country; (ii) characteristics of the experimental animals: animal model, age, weight, number of animals, number of animals per group, and number of groups; (iii) exposure: compounds, doses, periodicity of administration, route, duration, and existence of a control group; (iv) main histomorphological outcomes and analyses as well as the main molecular, biochemical, and hormonal results related with the histomorphological alterations; and (v) secondary outcomes.  The quality of the studies was assessed by the criteria described on the SYRCLE’s Risk of Bias (RoB) tool (Systematic Review Centre for Laboratory Animal Experimentation) designed specifically for animal studies.  Thirty-seven (37) records were included in the systematic review.

The scope of this project was limited to representing the AOP(s) as presented in the originating publication.  No editorilization   The literature used to support this AOP and its constituent pages began with the originating publication and followed to the primary, secondary, and tertiary works cited therein. 

KE and KER page creation and re-use was determined using Handbook principles where page re-use was preferred.  Once a baseline level of information was populated for the AOP the authors of the originating publication were contacted for collaboration.

Efforts were made not to editorialize or otherwise add any content to the AOP or its constituent pages that weren’t provided in the primary, secondary, or tertiary literature.  In some cases, however, descriptive content was added to pages e.g., assays on a KE page, even if they weren’t specifically provided in the literature stemming from the originating publication.

Summary of the AOP

This section is for information that describes the overall AOP.The information described in section 1 is entered on the upper portion of an AOP page within the AOP-Wiki. This is where some background information may be provided, the structure of the AOP is described, and the KEs and KERs are listed. More help

Events:

Molecular Initiating Events (MIE)
An MIE is a specialised KE that represents the beginning (point of interaction between a prototypical stressor and the biological system) of an AOP. More help
Key Events (KE)
A measurable event within a specific biological level of organisation. More help
Adverse Outcomes (AO)
An AO is a specialized KE that represents the end (an adverse outcome of regulatory significance) of an AOP. More help
Type Event ID Title Short name
MIE 2205 Increased, essential element imbalance Increased, essential element imbalance
KE 1115 Increased, Reactive oxygen species Increased, Reactive oxygen species
KE 1392 Oxidative Stress Oxidative Stress
KE 1445 Increase, Lipid peroxidation Increased, LPO
KE 2206 Increased, histomorphological alteration of testis Increased, histomorphological alteration of testis
KE 1758 Impaired, Spermatogenesis Impaired, Spermatogenesis
AO 2147 Decreased, Viable Offspring Decreased, Viable Offspring

Relationships Between Two Key Events (Including MIEs and AOs)

This table summarizes all of the KERs of the AOP and is populated in the AOP-Wiki as KERs are added to the AOP.Each table entry acts as a link to the individual KER description page. More help

Network View

This network graphic is automatically generated based on the information provided in the MIE(s), KEs, AO(s), KERs and Weight of Evidence (WoE) summary tables. The width of the edges representing the KERs is determined by its WoE confidence level, with thicker lines representing higher degrees of confidence. This network view also shows which KEs are shared with other AOPs. More help

Prototypical Stressors

A structured data field that can be used to identify one or more “prototypical” stressors that act through this AOP. Prototypical stressors are stressors for which responses at multiple key events have been well documented. More help

Life Stage Applicability

The life stage for which the AOP is known to be applicable. More help
Life stage Evidence
Adult, reproductively mature High
Adult High
Adults High

Taxonomic Applicability

Latin or common names of a species or broader taxonomic grouping (e.g., class, order, family) can be selected.In many cases, individual species identified in these structured fields will be those for which the strongest evidence used in constructing the AOP was available. More help
Term Scientific Term Evidence Link
Murinae gen. sp. Murinae gen. sp. High NCBI

Sex Applicability

The sex for which the AOP is known to be applicable. More help
Sex Evidence
Male High

Overall Assessment of the AOP

Addressess the relevant biological domain of applicability (i.e., in terms of taxa, sex, life stage, etc.) and Weight of Evidence (WoE) for the overall AOP as a basis to consider appropriate regulatory application (e.g., priority setting, testing strategies or risk assessment). More help

Domain of Applicability

Addressess the relevant biological domain(s) of applicability in terms of sex, life-stage, taxa, and other aspects of biological context. More help

Taxonomic applicability: Murine models were the focus of the originating publication however the broader concepts likely apply to broader taxonomic groups.

Life stage applicability: The originating publication dealt with adult, reproductively mature organisms since the KEs were investigated in testis tissues and cells.

Sex applicability: Limited to male sex as constrained by testis.

In vitro data is used to support these domains.

Essentiality of the Key Events

The essentiality of KEs can only be assessed relative to the impact of manipulation of a given KE (e.g., experimentally blocking or exacerbating the event) on the downstream sequence of KEs defined for the AOP. Consequently, evidence supporting essentiality is assembled on the AOP page, rather than on the independent KE pages that are meant to stand-alone as modular units without reference to other KEs in the sequence. The nature of experimental evidence that is relevant to assessing essentiality relates to the impact on downstream KEs and the AO if upstream KEs are prevented or modified. This includes: Direct evidence: directly measured experimental support that blocking or preventing a KE prevents or impacts downstream KEs in the pathway in the expected fashion. Indirect evidence: evidence that modulation or attenuation in the magnitude of impact on a specific KE (increased effect or decreased effect) is associated with corresponding changes (increases or decreases) in the magnitude or frequency of one or more downstream KEs. More help

Evidence Assessment

Addressess the biological plausibility, empirical support, and quantitative understanding from each KER in an AOP. More help

Known Modulating Factors

Modulating factors (MFs) may alter the shape of the response-response function that describes the quantitative relationship between two KES, thus having an impact on the progression of the pathway or the severity of the AO.The evidence supporting the influence of various modulating factors is assembled within the individual KERs. More help
Modulating Factor (MF) Influence or Outcome KER(s) involved
     

Quantitative Understanding

Optional field to provide quantitative weight of evidence descriptors.  More help

Considerations for Potential Applications of the AOP (optional)

Addressess potential applications of an AOP to support regulatory decision-making.This may include, for example, possible utility for test guideline development or refinement, development of integrated testing and assessment approaches, development of (Q)SARs / or chemical profilers to facilitate the grouping of chemicals for subsequent read-across, screening level hazard assessments or even risk assessment. More help

References

List of the literature that was cited for this AOP. More help